Campbell & Co Investment Adviser’s Moderna MRNA Stock Holding History

Campbell & Co Investment Adviser’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-33,849	Closed	-$998K	–	1289
2025 Q4	$998K	Buy	+33,849	New	+$920K	0.05%	566
2025 Q3	–	Sell	-53,333	Closed	-$1.47M	–	1289
2025 Q2	$1.47M	Buy	+53,333	New	+$1.4M	0.09%	348
2025 Q1	–	Sell	-7,027	Closed	-$292K	–	1222
2024 Q4	$292K	Sell	7,027 -8,439	-55%	-$403K	0.02%	856
2024 Q3	$1.03M	Buy	+15,466	New	+$1.42M	0.08%	428
2021 Q4	–	Sell	-1,000	Closed	-$385K	–	743
2021 Q3	$385K	Sell	1,000 -300	-23%	-$111K	0.13%	297
2021 Q2	$305K	Buy	+1,300	New	+$232K	0.13%	316

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Campbell & Co Investment Adviser's MRNA Position: Q1 2026 in Review

Campbell & Co Investment Adviser sold out of Moderna (MRNA) in Q1 2026, closing a stake of 33,849 shares — an estimated $998K sold.

Campbell & Co Investment Adviser first reported a position in MRNA in Q2 2021 and held it in 6 quarters. The position peaked at $1.47M in Q2 2025. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

Campbell & Co Investment Adviser reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
Campbell & Co Investment Adviser sold 33,849 Moderna shares in Q1 2026, an estimated $998K.
Campbell & Co Investment Adviser first reported a position in Moderna in Q2 2021 and held it in 6 quarters.
Campbell & Co Investment Adviser's Moderna position peaked at $1.47M in Q2 2025.
723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2026, filed 15 May 2026.